Adumbrations Of Aducanumab
Is the FDA too lax? Do bears go to the bathroom in spotless marble-floored lavatories? Is the Pope an Anabaptist?
In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.
'Some Hope Is Better Than Having No Hope' · The New York Times
Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget
Despite unproven efficacy, Biogen set the drug’s list price at $56,000 per year.
New Drug Could Cost the Government as Much as It Spends on NASA
The Alzheimer’s treatment will cost $56,000 per patient, and millions may use it. The result: “crazy numbers” for Medicare.
Spotify – A New Alzheimer's Drug Brings Hope and Controversy - The Journal. | Podcast on Spotify